Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 13-Feb-24 10:00 PM View:  | Zoetis Inc. (ZTS) | 10-Feb-24 | Option Exercise | 1,463 | -- | -- | 7% 20.32K to 21.78K | |
| 12-Feb-24 5:57 PM View: | Zoetis Inc. (ZTS) | 08-Feb-24 | Option Exercise | 1,493 | -- | -- | 8% 18.83K to 20.32K | |
| 16-Nov-23 4:11 PM View: | Mallinckrodt plc (MNKTQ) | 14-Nov-23 | Disposition | 32,048 | -- | -- | (100%) 32.05K to 0 | |
| 29-Jun-23 6:51 PM View: | Mallinckrodt plc (MNKTQ) | 16-Jun-23 | Disposition | 39,083 | -- | -- | (52%) 74.82K to 35.74K | |
| 29-Jun-23 6:51 PM View: | Mallinckrodt plc (MNKTQ) | 16-Jun-23 | Payment of Exercise | 3,689 | $1.28 | $4,721.92 | (10%) 35.74K to 32.05K | |
| 02-Jun-23 6:21 PM View: | Myriad Genetics Inc. (MYGN) | 01-Jun-23 | Grant | 7,575 | -- | -- | 45% 16.88K to 24.45K | |
| 16-Mar-23 10:00 PM View: | Mallinckrodt plc (MNKTQ) | 14-Mar-23 | Private Purchase | 5,000 | $8.47 | $42,329.50 | 7% 69.82K to 74.82K | |
| 14-Feb-23 4:46 PM View: | Zoetis Inc. (ZTS) | 11-Feb-23 | Option Exercise | 1,626 | -- | -- | 9% 17.2K to 18.83K | |
| 05-Jan-23 6:03 PM View: | Mallinckrodt plc (MNKTQ) | 03-Jan-23 | Grant | 39,083 | -- | -- | 127% 30.74K to 69.82K | |
| 01-Nov-22 4:31 PM View: | Myriad Genetics Inc. (MYGN) | 31-Oct-22 | Grant | 16,875 | -- | -- | 100% 0 to 16.88K | |
| 22-Aug-22 6:00 AM View: | Croff Enterprises Inc. (TXMD) | 18-Aug-22 | Option Exercise | 1,984 | -- | -- | 50% 3.94K to 5.92K | |
| 15-Feb-22 7:53 PM View: | Zoetis Inc. (ZTS) | 12-Feb-22 | Option Exercise | 2,673 | -- | -- | 18% 14.53K to 17.2K | |
| 18-Aug-21 6:03 AM View: | Croff Enterprises Inc. (TXMD) | 16-Aug-21 | Market Purchase | 50,000 | $0.79 | $39,500.00 | 34% 146.86K to 196.86K | (3%) |
| 12-Aug-21 9:36 PM View: | Croff Enterprises Inc. (TXMD) | 10-Aug-21 | Option Exercise | 96,864 | -- | -- | 194% 50.0K to 146.86K | |
| 17-Feb-21 5:16 PM View: | Zoetis Inc. (ZTS) | 13-Feb-21 | Option Exercise | 2,779 | -- | -- | 24% 11.75K to 14.53K | |
| 08-Jun-20 4:10 PM View: | Croff Enterprises Inc. (TXMD) | 04-Jun-20 | Market Purchase | 50,000 | $1.14 | $57,000.00 | 100% 0 to 50.0K | |
| 19-Feb-20 5:22 PM View: | Zoetis Inc. (ZTS) | 14-Feb-20 | Option Exercise | 3,704 | -- | -- | 46% 8.04K to 11.75K | |
| 09-May-19 5:43 PM View: | Amneal Pharmaceuticals, Inc. (AMRX) | 07-May-19 | Payment of Exercise | 12,529 | $13.44 | $168,390.00 | (30%) 41.98K to 29.45K | |
| 09-May-19 5:43 PM View: | Amneal Pharmaceuticals, Inc. (AMRX) | 07-May-19 | Option Exercise | 24,983 | -- | -- | 147% 17.0K to 41.98K | |
| 12-Mar-19 4:45 PM View: | Amneal Pharmaceuticals, Inc. (AMRX) | 12-Mar-19 | Market Purchase | 17,000 | $11.97 | $203,490.00 | 100% 0 to 17.0K | (< 1%) |
| 21-Feb-19 5:09 PM View: | Zoetis Inc. (ZTS) | 19-Feb-19 | Option Exercise | 4,150 | -- | -- | 107% 3.89K to 8.04K | |
| 04-May-18 6:18 PM View: | Allergan Plc (AGN) | 02-May-18 | Grant | 1,985 | $151.07 | $299,874.00 | < 1% 381.74K to 383.73K | (2%) |
| 03-May-18 9:55 AM View: | Allergan Plc (AGN) | 01-May-18 | Payment of Exercise | 588 | $152.94 | $89,928.70 | (< 1%) 382.33K to 381.74K | 3% |
| 03-May-18 5:15 PM View: | Zoetis Inc. (ZTS) | 01-May-18 | Option Exercise | 3,894 | -- | -- | 100% 0 to 3.89K | |
| 06-Mar-18 6:51 PM View: | Allergan Plc (AGN) | 05-Mar-18 | Payment of Exercise | 2,921 | $148.73 | $434,440.00 | (< 1%) 385.25K to 382.33K | < 1% |
| 02-Jan-18 4:38 PM View: | Allergan Plc (AGN) | 29-Dec-17 | Payment of Exercise | 6,521 | $163.58 | $1,066,710.00 | (2%) 391.77K to 385.25K | 10% |
| 30-Oct-17 9:19 PM View: | Allergan Plc (AGN) | 26-Oct-17 | Option Exercise | 37,727 | -- | -- | 11% 354.05K to 391.77K | |
| 05-May-17 6:26 PM View: | Allergan Plc (AGN) | 04-May-17 | Grant | 1,223 | $245.25 | $299,941.00 | < 1% 352.82K to 354.05K | (40%) |
| 05-May-17 6:26 PM View: | Allergan Plc (AGN) | 03-May-17 | Payment of Exercise | 214 | $243.76 | $52,164.60 | (< 1%) 353.04K to 352.82K | 40% |
| 07-Mar-17 4:53 PM View: | Allergan Plc (AGN) | 05-Mar-17 | Payment of Exercise | 2,862 | $245.63 | $702,993.00 | (< 1%) 355.9K to 353.04K | 40% |
| 06-Mar-17 6:59 AM View: | Allergan Plc (AGN) | 02-Mar-17 | Market Sale | 70,000 | $246.68 | $17,267,600.00 | (16%) 425.9K to 355.9K | 41% |
| 06-Feb-17 8:09 PM View: | Allergan Plc (AGN) | 02-Feb-17 | Grant | 444 | $229.52 | $101,907.00 | < 1% 425.46K to 425.9K | (36%) |
| 03-Feb-17 8:32 PM View: | Allergan Plc (AGN) | 01-Feb-17 | Grant | 7,105 | $229.32 | $1,629,320.00 | 4% 181.76K to 188.87K | (36%) |
| 03-Feb-17 8:32 PM View: | Allergan Plc (AGN) | 01-Feb-17 | Payment of Exercise | 3,411 | $229.32 | $782,211.00 | (2%) 188.87K to 185.46K | 36% |
| 24-Aug-15 6:28 PM View: | Allergan Plc (AGN) | 24-Aug-15 | Market Purchase | 1,000 | $297.42 | $297,422.00 | < 1% 420.75K to 421.75K | (51%) |
| 30-Dec-15 6:06 PM View: | Allergan Plc (AGN) | 31-Jul-15 | Gift | 120,000 | -- | -- | (22%) 541.75K to 421.75K | |
| 09-Mar-15 6:10 PM View: | Allergan Plc (AGN) | 05-Mar-15 | Grant | 13,702 | -- | -- | 3% 410.14K to 423.85K | |
| 09-Mar-15 6:10 PM View: | Allergan Plc (AGN) | 05-Mar-15 | Payment of Exercise | 3,092 | $295.70 | $914,304.00 | (< 1%) 423.85K to 420.75K | 51% |
| 13-May-14 5:20 PM View: | Allergan Plc (AGN) | 09-May-14 | Grant | 10,150 | $197.05 | $2,000,060.00 | 3% 400.0K to 410.14K | (26%) |
| 13-Nov-13 8:19 PM View: | Allergan Plc (AGN) | 11-Nov-13 | Market Sale | 40,921 | $158.73 | $6,495,570.00 | (9%) 440.92K to 400.0K | 8% |
| 02-Oct-13 8:44 PM View: | Watson Pharmaceuticals Inc. (ACT) | 01-Oct-13 | Disposition | 440,916 | -- | -- | (100%) 440.92K to 0 | |
| 03-Oct-13 4:17 PM View: | Allergan Plc (AGN) | 01-Oct-13 | Grant | 440,916 | -- | -- | 100% 0 to 440.92K | |
| 02-Oct-13 8:44 PM View: | Watson Pharmaceuticals Inc. (ACT) | 30-Sep-13 | Grant | 140,760 | -- | -- | 30% 462.23K to 602.99K | |
| 02-Oct-13 8:44 PM View: | Watson Pharmaceuticals Inc. (ACT) | 30-Sep-13 | Payment of Exercise | 162,076 | $144.00 | $23,338,900.00 | (27%) 602.99K to 440.92K | 83% |
| 17-Sep-13 8:20 PM View: | Watson Pharmaceuticals Inc. (ACT) | 13-Sep-13 | Gift | 7,000 | -- | -- | (1%) 469.23K to 462.23K | |
| 22-Aug-13 4:27 PM View: | Watson Pharmaceuticals Inc. (ACT) | 20-Aug-13 | Market Sale | 50,000 | $135.30 | $6,765,090.00 | (10%) 519.23K to 469.23K | 82% |
| 09-Aug-13 3:59 PM View: | Watson Pharmaceuticals Inc. (ACT) | 07-Aug-13 | Payment of Exercise | 324,061 | $135.43 | $43,887,600.00 | (38%) 843.29K to 519.23K | 82% |
| 09-Aug-13 3:59 PM View: | Watson Pharmaceuticals Inc. (ACT) | 07-Aug-13 | Option Exercise | 527,200 | $30.66 | $16,164,000.00 | 167% 316.09K to 843.29K | |
| 08-Mar-13 5:54 PM View: | Watson Pharmaceuticals Inc. (ACT) | 06-Mar-13 | Grant | 52,505 | -- | -- | 20% 263.59K to 316.09K | |
| 07-Mar-13 2:53 PM View: | Watson Pharmaceuticals Inc. (ACT) | 05-Mar-13 | Payment of Exercise | 19,068 | $86.46 | $1,648,620.00 | (7%) 282.66K to 263.59K | 72% |